BTAI is BioXcel Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.07. Market cap: $2M. Capital Quality Rank: 10/100 — Systemic risk.
Stock snapshot
| Price | $0.07 |
| Market cap | $2M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 10 / 100 · Systemic risk |
| Revenue CAGR (3y) | 19.6% |
| Shareholder buyback yield | -10.05% |
| Altman Z-score zone | Distress |
About BTAI
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are-BXCL501, being evaluated as a potential treatment for agitation associated with multiple neurological disorders and BXCL701, an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer and other solid and liquid tumors. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Related non-dividend companies
Other non-dividend stocks investors research alongside BTAI. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is BTAI's current stock price?
BTAI (BioXcel Therapeutics, Inc.) is currently trading at $0.07.
Does BTAI pay a dividend?
BTAI (BioXcel Therapeutics, Inc.) does not currently pay a regular dividend.
What is BTAI's Capital Quality Rank?
BTAI has a Capital Quality Rank of 10/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track BTAI in DiviDrip
Add BTAI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search BTAI and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.